Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Jerash Holdings (US) (JRSH) EBITDA (2016 - 2025)

Jerash Holdings (US) (JRSH) has disclosed EBITDA for 10 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 1003.38% year-over-year to $1.2 million, compared with a TTM value of $2.0 million through Dec 2025, up 146.4%, and an annual FY2025 reading of -$860732.0, up 64.3% over the prior year.
  • EBITDA was $1.2 million for Q4 2025 at Jerash Holdings (US), up from $462088.0 in the prior quarter.
  • Across five years, EBITDA topped out at $4.4 million in Q3 2021 and bottomed at -$3.4 million in Q1 2024.
  • Average EBITDA over 5 years is $482267.6, with a median of $431272.0 recorded in 2023.
  • The sharpest move saw EBITDA skyrocketed 1445.74% in 2021, then plummeted 1659.53% in 2023.
  • Year by year, EBITDA stood at $1.7 million in 2021, then tumbled by 45.92% to $928622.0 in 2022, then crashed by 65.76% to $317968.0 in 2023, then crashed by 142.35% to -$134655.0 in 2024, then soared by 1003.38% to $1.2 million in 2025.
  • Business Quant data shows EBITDA for JRSH at $1.2 million in Q4 2025, $462088.0 in Q3 2025, and $328240.0 in Q2 2025.